23 May 2013
Keywords: pegasys, offers, better, qol, vs, trad, therapy
Article | 11 March 2002
Key quality of life factors that influence patients discontinuing theirhepatitis C virus therapy are published in a new study in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 March 2002
22 May 2013
© 2013 thepharmaletter.com